This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

If Hedge Funds Are Interested in Arena Pharma, It's On The Short Side

Stocks in this article: ARNA VVUS

BOSTON ( TheStreet) -- Over at Motley Fool, Michael Meyer says hedge funds are interested in Arena Pharmaceuticals (ARNA). True, but not in the way he means.

Meyer:

Arena has seen hedge funds acquire roughly 29 million shares during the most recent quarter. The largest holder of Arena shares is Wellington Capital. Since the company has roughly 215 million outstanding shares, institutions acquired roughly 13% of the company's float. This is a pretty strong indicator that the company may have a promising 2013.

Meyer's reasoning is off track. Hedge funds aren't interested in Arena, at least not on the long side, according to third-quarter ownership data. Wellington Capital is a long-only mutual fund investment adviser, not a hedge fund.

There were 136 institutional investors who filed 13Fs listing Arena among their stock holdings at the end of the third quarter, according to Whalewisdom.com. The aggregate number of Arena shares in these 13Fs totaled 95.6 million shares at Sept. 30, 2012, an increase of 29 million shares, or 42%, over the June 30, 2012 filings.

Twenty-seven institutional investors opened new positions in Arena in the third quarter, and another 69 funds added to existing positions. But remember, when an investors buys a share of Arena, another investor is selling. So, in the third quarter, 51 funds closed out their Arena positions with another 48 funds reducing their positions, according to Whalewisdom.com.

Hedge funds are under-represented among Arena shareholders, owning just 6% of the company -- defined as owning less than 5% stakes in the company. No hedge fund owned more than 5% of Arena. Traditional investment managers (think mutual funds) own 37% of Arena, according to CapitalIQ.

Arena's overall institutional investor ownership is 47%, which includes mutual funds (37%) and hedge funds owning stakes smaller than 5% (6%). Public ownership of the company (think retail investors) stands at 52%, according to CapitalIQ.

Arena is often referred to a retail investor-driven stock, so now you know why. Institutional investor ownership in the company is increasing but "Wall Street" still owns less than half of the outstanding shares.

Fourth-quarter ownership data won't be available until the middle of February.

How does Arena stack up against its weight-loss competitor Vivus (VVUS)?

Total institutional investor ownership of Vivus was 62% of Vivus at the end of the third quarter, which included 42% ownership by mutual funds and 12% from hedge funds with less than a 5% stake, according to CapitalIQ.

Hedge funds with more than a 5% stake in the company represented 17% of Vivus' outstanding shares, according to CapitalIQ.

Meyer is right about hedge funds being interested in Arena, but I'm pretty sure it's on the short side. Arena's short interest stood at 52 million shares at the end of 2012 -- or approximately 22% of the company's 234 million fully diluted outstanding shares. Exact figures aren't available but assume safely that the lion's share of those 52 million short shares held by hedge funds.

-- Reported by Adam Feuerstein in Boston.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs